Abstract: Disclosed herein is a method and system for separating carbon dioxide (CO2) from a CO2 containing gas stream containing water vapor and additional impurities, for example, nitrogen, oxygen, sulfur oxides, nitrogen oxides, and mercury. The CO2 is captured by subjecting the CO2 gas feed stream to a temperature swing adsorption step. The temperature swing adsorption step comprises an adsorption step for producing a substantially dry carbon dioxide-depleted stream, and an adsorbent regeneration step comprising heating the adsorbent bed to produce a substantially water vapor-free carbon dioxide stream. Moisture from the gas stream containing CO2 is optionally removed by pressure swing adsorption, temperature swing adsorption, membrane separation, or absorption prior to CO2 capture.

Abstract: Compounds, compositions and methods are provided for modulating the expression of eIF4E-BP2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding eIF4E-BP2. Methods of using these compounds for modulation of eIF4E-BP2 expression and for diagnosis and treatment of diseases and conditions associated with expression of eIF4E-BP2 are provided.

Abstract: Compounds, compositions and methods are provided for modulating the levels expression, processing and function of pri-miRNAs. In particular, methods and compounds are provided for the modulation of the levels, expression, processing or function of polycistronic pri-miRNAs. The compositions comprise oligomeric compounds targeted to small non-coding RNAs and pri-miRNAs. Further provided are methods for selectively modulating pri-miRNA levels in a cell. Also provided are methods for identifying oligomeric compounds that result in increase pri-miRNA levels when contacted with a cell.

Abstract: Compounds, compositions and methods are provided for modulating the expression of growth hormone receptor and/or insulin like growth factor-I (IGF-I). The compositions comprise oligonucleotides, targeted to nucleic acid encoding growth hormone receptor. Methods of using these compounds for modulation of growth hormone receptor expression and for diagnosis and treatment of disease associated with expression of growth hormone receptor and/or insulin-like growth factor-I are provided. Diagnostic methods and kits are also provided.

Abstract: The present invention provides for an improved process for producing ozone which can be used to remove contaminants from gas streams in industrial processes. The improved process uses a separation device after the ozone generating system to separate the ozone from the oxygen gas and directs the ozone to the industrial process and the oxygen back to the feedstream entering the ozone generating system. The improved process further provides for the use of ozone so generated to removed contaminants from industrial process flue gas streams.

Abstract: Compounds, compositions and methods are provided for modulating the levels expression, processing and function of pri-miRNAs. In particular, methods and compounds are provided for the modulation of the levels, expression, processing or function of polycistronic pri-miRNAs. The compositions comprise oligomeric compounds targeted to small non-coding RNAs and pri-miRNAs. Further provided are methods for selectively modulating pri-miRNA levels in a cell. Also provided are methods for identifying oligomeric compounds that result in increase pri-miRNA levels when contacted with a cell.

Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.

Abstract: Among other disclosed subject matter, a computer-implemented method for providing content distribution for a mobile device includes providing a software development kit to a developer for developing an application for a mobile device. The software development kit includes an object to be inserted into the application and configured for requesting content for the application. The method includes identifying a context parameter regarding the application for use in selecting content to be distributed to the application on the mobile device. The method includes forwarding the content to the mobile device, the content being selected using the context parameter and configured to be presented to a user of the mobile device.

Abstract: The invention pertains to location approximation of devices, e.g., wireless access points and client devices in a wireless network. Location estimates may be obtained by observation/analysis of packets transmitted or received by the access point. For instance, data rate information associated with a packet is used to approximate the distance between a client device and the access point. This may be coupled with known positioning information to arrive at an approximate location for the access point. Confidence information and metrics about whether a device is an access point and the location of that device may also be determined. Accuracy of the location determination may be affected by factors including propagation and environmental factors, transmit power, antenna gain and diversity, etc. A location information database of access points may employ measurements from various devices over time. Such information may identify the location of client devices and provide location-based services to them.

Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.

Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.

Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.

Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.

Abstract: Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided.

Abstract: An implantable cardioverter defibrillator (ICD) including a set of leads having electrodes disposed therein. The electrodes may include a weld electrode connected to an internal wire of the lead and the ICD and a tip electrode. The tip electrode may have a set of grooves or cut out regions in its outer surface to provide edge effects for currents applied through the tip electrode. The grooves or cut out regions may form gaps in the surface of the tip electrode exposing a medical compound that is housed within the tip electrode. The medical compound may elute through the gaps.

Abstract: The present invention provides for a process for purifying carbon monoxide-containing gas streams that contain impurities such as hydrocarbons by using a cryogenic adsorption process. Preferably this process is a temperature swing adsorption process at cryogenic temperatures below ?75° C. Alternatively, the carbon monoxide-containing gas streams may be purified using the cryogenic adsorption process with membrane separation units or vacuum swing adsorption units or cryogenic distillation.

Abstract: An implantable cardioverter defibrillator (ICD) including a set of leads having electrodes disposed therein. The electrodes may include a weld electrode connected to an internal wire of the lead and the ICD and a tip electrode. The tip electrode may have a set of grooves or cut out regions in its outer surface to provide edge effects for currents applied through the tip electrode. The grooves or cut out regions may form gaps in the surface of the tip electrode exposing a medical compound that is housed within the tip electrode. The medical compound may elute through the gaps.

Abstract: Compounds, compositions and methods are provided for modulating the expression of eIF4E-BP2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding eIF4E-BP2. Methods of using these compounds for modulation of eIF4E-BP2 expression and for diagnosis and treatment of diseases and conditions associated with expression of eIF4E-BP2 are provided.

Abstract: The present invention provides for a method for purifying carbon dioxide. Moisture, sulfur species and other impurities are removed from the carbon dioxide by a series of steps which include adsorption means and reaction means. All the steps are preferably carried out in a single vessel.

Abstract: This invention provides a process for the detoxification of chemical agents including chemical warfare agents such as sulfur mustards, nitrogen mustards, nerve agents of G and V type, lewisite and adamsite by reacting the chemical agents with hydroxyl radicals at a pH greater than 7.0 to detoxify the agents and to render them suitable for disposal. The process can be used on-site and can be easily scaled to fairly large sizes.